Gregory J. Bullington

Greg Bullington, Chief Executive Officer and co-founder, has led all aspects of company development since inception including clinical trial design and execution, peer-reviewed publications, product development, manufacturing, commercialization strategy, and intellectual property strategy.

To date, Greg has raised over $115 million in capital to drive the successful growth and development of the company.

Greg has extensive experience in the healthcare industry has led product commercialization and strategy engagements for a wide variety of companies in the biotech (novel immunotherapy), healthcare insurance, wellness, and enterprise software sectors.

Greg began his career in professional services with Deloite & Touche LLP. He continued his professional development as a management consultant with Lake Partners, a Seatle-based strategy firm. In 2006, Greg founded Forum Ventures, a technology commercialization consultancy focused on accelerating the growth of early and mid-stage technology companies in a variety of sectors.

Over the past 20 years, Greg has led engagements and worked with senior executive teams at over 50 companies ranging from Fortune 100 corporations to venture-backed and early-stage startups as a consultant, advisor, and investor.

Additionally, Greg has significant intellectual property expertise. He is the first named inventor on more than 80 issued patents, as well as over 50 pending US and international patent applications.